Urological Cancer 2020
Urological Cancer 2020
English[eng]
9783040000000
renal cell carcinoma||iron||macrophages||chelation therapy||urothelial carcinoma||transcriptome||microtubule||MAP1B||prognosis||KLF5||androgen receptor||cell proliferation||tumorigenesis||prostate cancer||precision medicine||whole genome sequencing||optical mapping||therapy||prostate carcinoma||prostate mpMRI||machine learning||artificial intelligence||deep learning||neural network||angiogenesis||angiogenic growth factors||antiangiogenic therapy||renal tumors||prevention||α1-adrenoceptor antagonists||anoikis||vascularity||research model||oncogenes||tumor suppressor genes||MR-guided||radiotherapy||MRgRT||stereotactic ablative radiotherapy||stereotactic ablative radiation therapy (SABR)||renal cell cancer||RCC||online adaptive||[68Ga]Ga-PSMA PET/CT||dual-time point imaging||delayed imaging||biphasic imaging||lesion positivity rate||CXCL9||PD1||PD-L1||stage T1 NMIBC||prostatic neoplasms/mortality||prostatic neoplasms/epidemiology||SEER Program||bladder cancer||transurethral resection||en-bloc resection||CPT1A||fatty acids||serine||androgen response||ROS||oxidative stress||DONSON||Downstream Neighbor of SON||biomarker||metastatic spread||diagnosis||differential diagnosis||histopathology||immunohistochemistry||stroma signature||patient-derived xenografts||n/a
English[eng]
9783040000000
renal cell carcinoma||iron||macrophages||chelation therapy||urothelial carcinoma||transcriptome||microtubule||MAP1B||prognosis||KLF5||androgen receptor||cell proliferation||tumorigenesis||prostate cancer||precision medicine||whole genome sequencing||optical mapping||therapy||prostate carcinoma||prostate mpMRI||machine learning||artificial intelligence||deep learning||neural network||angiogenesis||angiogenic growth factors||antiangiogenic therapy||renal tumors||prevention||α1-adrenoceptor antagonists||anoikis||vascularity||research model||oncogenes||tumor suppressor genes||MR-guided||radiotherapy||MRgRT||stereotactic ablative radiotherapy||stereotactic ablative radiation therapy (SABR)||renal cell cancer||RCC||online adaptive||[68Ga]Ga-PSMA PET/CT||dual-time point imaging||delayed imaging||biphasic imaging||lesion positivity rate||CXCL9||PD1||PD-L1||stage T1 NMIBC||prostatic neoplasms/mortality||prostatic neoplasms/epidemiology||SEER Program||bladder cancer||transurethral resection||en-bloc resection||CPT1A||fatty acids||serine||androgen response||ROS||oxidative stress||DONSON||Downstream Neighbor of SON||biomarker||metastatic spread||diagnosis||differential diagnosis||histopathology||immunohistochemistry||stroma signature||patient-derived xenografts||n/a